4+ hour, 9+ min ago  (11+ words) ICER Publishes Draft Evidence Report on Vaccines for Covid-19 NAVLIN DAILY...

2+ day, 15+ hour ago  (12+ words) Interpharma Warns that New U. S. Tariffs Will Impact Swiss Patients'NAVLIN DAILY...

1+ week, 3+ day ago  (80+ words) Solving The Rare Disease Launch Paradox " Using Pre'Launch Planning and Partnership to Create Value EVERSANA's AI Agency Platform Wins 2026 AI Excellence Award It's Time for Commercialization to Catch Up to Innovation in Women's Health 4th Annual Brand Planning Report: Fueling Brand…...

3+ week, 6+ day ago  (1805+ words) NAVLIN Daily (ND): Hi, Neil. I went to your talk earlier, it really was a whistle-stop tour. There has been so much going on. As you mentioned, MFN has put some companies on pause in Europe. That directly contradicts the…...

4+ week, 1+ hour ago  (59+ words) Gartner Is Right " About the Wrong Kind of Agency AI Platform Advancing Medical Affairs Through Data and Scientific Communications: Key Takeaways from DIA MASC 2026 Scaling Practical AI Across Commercial Teams Key Implications of Recent U. S. PBM Reforms Building a scalable GLP…...

4+ week, 1+ day ago  (61+ words) Key Implications of Recent U. S. PBM Reforms Building a scalable GLP-1 care model Navigating the Intersection of AI, Global Commercialization and Patient Value Recognizing Rare Disease Day: Advancing Hope, Access and Innovation Why Our AI Agency Is So Much More Than…...

4+ week, 2+ day ago  (61+ words) Key Implications of Recent U. S. PBM Reforms Building a scalable GLP-1 care model Navigating the Intersection of AI, Global Commercialization and Patient Value Recognizing Rare Disease Day: Advancing Hope, Access and Innovation Why Our AI Agency Is So Much More Than…...

4+ week, 2+ day ago  (632+ words) BRUSSELS, Belgium " The EU has set out the terms of a new launch obligation for medicines, requiring pharmaceutical companies to make approved drugs available in requesting Member States within three years or risk losing regulatory market protection in that country....

1+ mon, 3+ day ago  (546+ words) AMSTERDAM, The Netherlands " Most Favored Nation (MFN) is already reshaping global launch strategies; that was the central message from a pricing panel at the World Evidence, Pricing and Access (EPA) Congress in Amsterdam, where speakers warned that the policy's ripple…...

1+ mon, 3+ day ago  (67+ words) Building a scalable GLP-1 care model Navigating the Intersection of AI, Global Commercialization and Patient Value Recognizing Rare Disease Day: Advancing Hope, Access and Innovation Why Our AI Agency Is So Much More Than Chat GPT for Life Sciences Marketing…...